calendar
8,093 catalysts · 5,443 phase readout · 2,304 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom
8,093 catalysts · 5,443 phase readout · 2,304 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 3.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 1.01, 2.02, 7.01, 9.01
Items: 8.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 3.02, 9.01
Items: 2.02
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 3.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 3.02, 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 9.01
Items: 1.02
Items: 5.02
Items: 2.03, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 5.02, 8.01, 9.01
Items: 7.01, 9.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01